What is the first drug to administer in cardiac arrest?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

First Drug to Administer in Cardiac Arrest

In a patient with cardiac arrest, epinephrine (1 mg IV/IO) is the first drug that should be administered every 3-5 minutes regardless of the rhythm. 1, 2

Medication Administration in Cardiac Arrest

Initial Management

  • Ensure high-quality CPR is ongoing (100-120 compressions/minute, depth of at least 2 inches/5 cm)
  • Check rhythm to determine if shockable (VF/pVT) or non-shockable (asystole/PEA)
  • If rhythm is shockable (VF/pVT):
    • Deliver shock immediately
    • Resume CPR for 2 minutes
    • Administer epinephrine 1 mg IV/IO
  • If rhythm is non-shockable (asystole):
    • Continue CPR
    • Administer epinephrine 1 mg IV/IO as soon as possible

Epinephrine Administration

  • Dose: 1 mg IV/IO every 3-5 minutes 1, 2
  • For non-shockable rhythms: Give as soon as feasible after onset of arrest 1
  • For shockable rhythms: Administer after the third shock if the patient remains in cardiac arrest 1

Rationale for Epinephrine

Epinephrine works through its alpha-adrenergic effects to increase coronary perfusion pressure and cerebral perfusion pressure during CPR 1. The alpha-adrenergic effects improve cerebral and myocardial blood flow by preventing arterial collapse and increasing peripheral vasoconstriction 3.

Additional Medication Considerations

Amiodarone or Lidocaine

  • Only indicated for shock-resistant VF/pVT
  • Amiodarone: 300 mg IV/IO bolus, followed by 150 mg if needed 1
  • Lidocaine: 1-1.5 mg/kg IV/IO, followed by 0.5-0.75 mg/kg if needed 1

Timing Considerations

While the 2020 AHA guidelines recommend epinephrine as the first drug for cardiac arrest, timing may vary slightly based on the initial rhythm:

  • For non-shockable rhythms: Administer as soon as possible 1
  • For shockable rhythms: Some evidence suggests administering after the third shock if defibrillation is unsuccessful 1

Common Pitfalls to Avoid

  1. Delaying epinephrine administration - For non-shockable rhythms, early administration of epinephrine (within 5 minutes) may increase survival-to-discharge rates 1

  2. Excessive focus on airway management - While securing the airway is important, it should not delay or interrupt chest compressions or epinephrine administration

  3. Inappropriate dosing - Standard dose of 1 mg is recommended; higher doses have not been shown to improve survival to hospital discharge 4

  4. Administering epinephrine too early in shockable rhythms - For VF/pVT, early epinephrine (before adequate defibrillation attempts) may be associated with decreased odds of survival 5

  5. Interrupting chest compressions - Medication administration should not cause significant interruptions in chest compressions

The 2020 AHA guidelines provide clear direction that epinephrine is the first-line medication for cardiac arrest, with the timing of administration dependent on the initial rhythm but generally recommended every 3-5 minutes throughout the resuscitation effort 1, 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.